Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Characteristics and Conflicts of Public Speakers at Meetings of the Oncologic Drugs Advisory Committee to the US Food and Drug Administration.

× No keyword cloud information.

8 in total

1. Association Between Food and Drug Administration Advisory Committee Recommendations and Agency Actions, 2008-2015.

Authors: Audrey D Zhang; Jason L Schwartz; Joseph S Ross
Journal: Milbank Q Date: 2019-07-14 Impact factor: 4.911

2. Health policy: Addressing conflicts of interest of public speakers at advisory committee meetings.

Authors: Matthew S McCoy; Ezekiel J Emanuel
Journal: Nat Rev Clin Oncol Date: 2016-04-13 Impact factor: 66.675

3. Conflicts of Interest of Public Speakers at Meetings of the Anesthetic and Analgesic Drug Products Advisory Committee.

Authors: Matthew S McCoy; Olivia Pagán; Gabrielle Donohoe; Genevieve P Kanter; Ronald S Litman
Journal: JAMA Intern Med Date: 2018-07-01 Impact factor: 21.873

4. Conflicts of interest in clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews: associations with recommendations.

Authors: Camilla Hansen Nejstgaard; Lisa Bero; Asbjørn Hróbjartsson; Anders W Jørgensen; Karsten Juhl Jørgensen; Mary Le; Andreas Lundh
Journal: Cochrane Database Syst Rev Date: 2020-12-08

Characteristics and Conflicts of Public Speakers at Meetings of the Oncologic Drugs Advisory Committee to the US Food and Drug Administration.

1. Association Between Food and Drug Administration Advisory Committee Recommendations and Agency Actions, 2008-2015.

2. Health policy: Addressing conflicts of interest of public speakers at advisory committee meetings.

3. Conflicts of Interest of Public Speakers at Meetings of the Anesthetic and Analgesic Drug Products Advisory Committee.

4. Conflicts of interest in clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews: associations with recommendations.

5. Financial relationships between patient and consumer representatives and the health industry: A systematic review.

6. Describing Sources of Uncertainty in Cancer Drug Formulary Priority Setting across Canada.

7. Industry funding of patient and health consumer organisations: systematic review with meta-analysis.

8. Characteristics of Open Public Hearing Speakers of the Tobacco Products Scientific Advisory Committee meetings.